News Archive

Date: 06/04/2012
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59% of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Date: 06/04/2012
Over men 1200 men with metastatic, hormone-sensitive prostate cancer were given intermittent androgen-deprivation (AD) therapy after seven months of androgen deprivation. The results show intermittent hormone therapy offers some quality-of-life benefits, but lower overall survival.
Date: 05/21/2012
Cancer survivors, their families and friends will be playing the hope card on June 3, 2012.
Date: 05/21/2012
Initial results from a first-of-its-kind international consortium of adrenal cancer researchers suggest there might be a treatment standard for patients with adrenal cancer, an extremely rare and deadly disease.
Date: 05/15/2012
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.
Date: 05/14/2012
The May 19, 2012 Men's Fellowship Breakfast event will feature cooking demonstration, food tasting.
Date: 05/14/2012
The use of single positron emission computed tomography (SPECT)/computed tomography (CT) has been reported to change clinical management in a significant number of thyroid cancer patients, according to research presented in the May issue of The Journal of Nuclear Medicine.
Date: 05/04/2012
May 10, 2012 web chat focuses on skin cancer, including melanoma and the genetic risk factors.
Date: 04/30/2012
G. Lita Smith, M.S., R.N., A.C.N.P., a nurse practitioner in the Breast Care Center and nurse practitioner supervisor at the U-M Comprehensive Cancer Center, is one of 11 cancer care providers being honored with the 2012 American Cancer Society Lane W. Adams Quality of Life Award.
Date: 04/24/2012
Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially leading to more mastectomies over breast-conserving therapy.

Pages